Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
1.520
-0.010 (-0.65%)
Aug 28, 2026, 1:39 PM EDT - Market open
Pluri Employees
As of June 30, 2025, Pluri had 142 total employees, including 127 full-time and 15 part-time employees. The number of employees increased by 24 or 20.34% compared to the previous year.
Employees
142
Change (1Y)
24
Growth (1Y)
20.34%
Revenue / Employee
$7,599
Profits / Employee
-$179,852
Market Cap
16.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 142 | 24 | 20.34% | 127 | 15 |
| Jun 30, 2024 | 118 | -16 | -11.94% | 106 | 12 |
| Jun 30, 2023 | 134 | -25 | -15.72% | 123 | 11 |
| Jun 30, 2022 | 159 | -3 | -1.85% | 154 | 5 |
| Jun 30, 2021 | 162 | 4 | 2.53% | 153 | 9 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Palatin Technologies | 29 |
| Citius Pharmaceuticals | 23 |
| BioCardia | 21 |
| Lipocine | 14 |
| NewcelX | 12 |
| Psyence Biomedical | 12 |
| Lexaria Bioscience | 7 |
| Pasithea Therapeutics | 5 |
PLUR News
- 1 day ago - Pluri prices 2.23M shares at $1.50 in registered direct offering - TheFly
- 1 day ago - Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor - GlobeNewsWire
- 11 days ago - Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - GlobeNewsWire
- 4 weeks ago - Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK - GlobeNewsWire
- 6 weeks ago - Pluri announces chairman Alejandro Weinstein ownership surpasses 30% - TheFly
- 2 months ago - Plurilock Announces Results of Annual General Meeting - Newsfile Corp
- 3 months ago - Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing - GlobeNewsWire
- 5 months ago - Pluri announces additional $2.5M investment from Alejandro Weinstein - TheFly